collins_genomicsNature2003

Yet this problem can be solved vigorous development

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: allenges in identifying and quantifying environmental exposures, technological obstacles to generating sufficient and useful genotypic information, and the difficulties of studying humans. Yet this problem can be solved. Vigorous development of crosscutting genomic tools to catalyse advances in understanding the genetics of common disease and in pharmacogenomics is needed. Prominent among these will be a detailed haplotype map of the human genome (see Grand Challenge I-3) that can be used for whole-genome association studies of all diseases in all populations, as well as further advances in sequencing and genotyping technology to make such studies feasible (see ‘Quantum leaps’, below). More efficient strategies for detecting rare alleles involved in common disease are also needed, as the hypothesis that alleles that increase risk for common diseases are themselves common30 will probably not be universally true. Computational and experimental methods to detect gene–gene and gene–environment interactions, as well as methods allowing interfacing of a variety of relevant databases, are also required (Box 3). By obtaining unbiased assessments of the relative disease risk that particular gene variants contribute...
View Full Document

This document was uploaded on 04/02/2014.

Ask a homework question - tutors are online